Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 4.8B | 4.2B | 4.6B | 4.3B |
Cost of revenue | 2.8B | 2.4B | 2.5B | 2.3B |
Gross profit | 2.0B | 1.7B | 2.2B | 2.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 90M | — | — | — |
Operating income | 1.9B | 1.7B | 2.2B | 2.0B |
Non operating interest income | ||||
Income | — | 36M | 39M | 12M |
Expense | — | 846M | 885M | 943M |
Other income expense | — | — | — | — |
Pretax income | -344M | -992M | -1.4B | -245M |
Tax provision | 423M | 150M | -48M | 99M |
Net income | -767M | -1.1B | -1.3B | -179M |
Basic EPS | -7.6 | -10.0 | -11.1 | -2.0 |
Diluted EPS | -7.6 | -10.0 | -11.1 | -2.0 |
Basic average shares | 1.2B | 1.2B | 1.2B | 1.2B |
Diluted average shares | 1.2B | 1.2B | 1.2B | 1.2B |
EBITDA | 2.7B | 843M | -183M | 1.0B |
Net income from continuing op. | 570M | -125M | 1.2B | 767M |
Minority interests | -147M | -69M | -75M | -60M |
Preferred stock dividends | 0 | 0 | 0 | 0 |